ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998